Mednet Logo

What is your preferred approach to adjuvant therapy for a Masaoka Stage III thymic carcinoma after R1 resection?

Would you elect for concurrent chemoRT or RT alone?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Answered on

The data for adjuvant treatment of thymic carcinoma is relatively scarce, with most studies and series on this topic have traditionally included all thymic malignancies including thymomas. In the scenario presented in the question, there are multiple risk factors- thymic carcinoma, R1 resection both...

Join for free or sign in to see the full answer